Kanvas Biosciences

About:

Mapping interactions foundational to therapeutic discovery and human health.

Website: https://www.kanvasbio.com/

Twitter/X: kanvasbio

Top Investors: DCVC, Pangaea Ventures, FemHealth Ventures, Uncommon Denominator, Germin8 Ventures

Description:

Our full-stack tech­nol­o­gy plat­form brings micro­bio­me drug dis­cov­ery into focus. Our spa­tial map­ping dis­cov­ery engine pro­vides stun­ning pic­tures of the inter­ac­tions and con­nec­tions between host and the micro­bio­me; an area of this vital sys­tem that we’ve nev­er been able to com­plete­ly under­stand before. Spa­tial biol­o­gy of the host-micro­bio­me inter­face pro­vides new oppor­tu­ni­ties for effec­tive ther­a­peu­tic inter­ven­tions, ulti­mate­ly enabling us to bet­ter treat patients.

Total Funding Amount:

$28.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Monmouth Junction, New Jersey, United States

Founded Date:

2020-12-01

Contact Email:

contact(AT)kanvasbio.com

Founders:

Hao Shi, Matthew Cheng

Number of Employees:

11-50

Last Funding Date:

2024-07-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai